Arencibia GD, Santana AE, Cruz BM, Garcés FA, Barroso LR

Language: Spanish
References: 17
Page: 330-338
PDF size: 140.10 Kb.

ABSTRACT

Cysticercosis brings about a group of zoonotic parasitic diseases, when it deals with the eye and its appendices, then ocular and periocular cistercosis emerges. It is one of the causes of ocular uveítis and significant loss of vision. The clinical diagnosis is made by direct observation of the parasite. If there are opacities, then the ultrasound technique is the useful diagnostic means. The steroid-related antihelminthic drugs are part of the treatment together with the final extraction of the parasite through pars plana vitrectomy. The most important characteristics of the clinical picture, the diagnosis, the management and the progression and treatment of a patient suffering this disease is presented in this article.

REFERENCES

1. Deza L. Hipólito Unanue y la Neurocisticercosis. Rev Neuropsiquiatr. 1987;50(2):77-82.

2. Garcia HH, Del Brutto OH. T. solium taeniasis/cysticercosis. Infect Dis Clin North Am. 2000;14(6):97-120.

3. Jiménez PE, Rowlands F. Cisticercosis ocular. Medicina. 2010;70(2):170

4. American Academic Ophthalmology. Intraocular inflammation and Uveitis. The eye. MD association. Base Clinical Scienci Course. Uveítis infecciosas. Edición de 2008-2009. P. 264.

5. Garcia HH, Gonzalez AE, Rodriguez S, Gonzalvez G, Llanos-Zavalaga F, Tsang V, et al. Epidemiology and control of cysticercosis in Peru. Rev Peru Med Exp y Salud Pública. 2010;27(4):592-7.

6. Phiri IK, Ngowi H, Afonso S, Matenga E, Boa M, Mukaratirwa S, et al. The emergence of Taeniasoliumcysticercosis in eastern and southern Africa as a serious agricultural problem and public health risk. Acta Trop. 2003;87(1):13-23.

7. Sorvillo F, Wilkins P, Shafir S, Eberhard M. Public Health Implications of Cysticercosis Acquired in the United States. Emerg Infect Dis. 2011;17(1):1-6.

8. García HH, Gilman R, Martinez M, Tsang VCW, Pilcher JB, Herrera G, et al. Cysticercosis as a major cause of epilepsy in Peru. Cysticercosis Working Group in Peru (CWG). The Lancet. 1993;341(8839):197-200.

9. Guerrant, RL. Ryan ET, Maguire JH. Enfermedades infecciosas tropicales: Parasitc infections and the eyes. En: Alber DM, Jacobiee FA, editors. Principle and practice of Ophthalmology. Philadelphy: BA Saunders; 2000. p. 1724-8.

10. Del Brutto OR, Rajshekhar V, White AC, Tsang VCW, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001;57(2):177-83.

11. Ciancas E, editors. Controversia en el diagnóstico y tratamiento Uveítis. Uveítis infecciosas. [Internet]. Madrid: Boletín de la Soc Esp, 2009 [citado 2010]. Disponible en: http://www.oftalmo.com/som/revist -2009/m2009-12.htm

12. Escobedo F, Gomez A, Ruiz S. Neurosurgical aspects of Neurocysticercosis. En: Schmidek HH, editors. Operative Neurosurgical Techniques. Philadelphia: Saunders WB; 2000. p. 1756-68.

13. Burchard GD, Reimold-Jehle U, Burkle V. Splenectomy for suspected malignant lymphoma in two patients with loiasis. Clin Infect Dis. 1996;23(5):979-82.

14. Del Brutto OH, Sotelo J. Neurocysticercosis: an update. Rev Infect Dis. 1988;10(6):1075-87.

15. Sotelo J, Escobedo F, Rodriguez-Carbajal J, Torres B, Rubio-Donnadieu F. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med. 1984;310(16):1001-7.

16. Vázquez ML, Jung H, Sotelo J. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology. 1987;37(9):1561-2.

17. Jung H, Hurtado M, Medina MT, Sanchez M, Sotelo J. Dexamethasone increases plasma levels of albendazole. J Neurol. 1990;237(5):279-80.